![Evdoxia E. Kopsidas](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Evdoxia E.
Kopsidas has been Interim Chief Accounting Officer of Novavax, Inc. since February 6, 2009 and Finance Director since October 2006.
Ms. Kopsidas was Controller of BioVeris Corporation from June 2004 to October 2006.
She held various positions with BioReliance Corporation from 1998 to June 2004 and served as Controller.
Anciens postes connus de Evdoxia E. Kopsidas
| Sociétés | Poste | Fin |
|---|---|---|
| NOVAVAX, INC. | Directeur Financier/CFO | 18/08/2009 |
BioVeris Corp.
 BioVeris Corp. BiotechnologyHealth Technology Develops and manufactures diagnostic products | Comptroller/Controller/Auditor | 01/10/2006 |
BioReliance Corp.
 BioReliance Corp. Pharmaceuticals: MajorHealth Technology Povides testing and manufacturing services | Comptroller/Controller/Auditor | 01/06/2004 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
24
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Novavax, Inc.
 Novavax, Inc. BiotechnologyHealth Technology Engages in development of novel recombinant vaccines | Health Technology |
BioReliance Corp.
BioReliance Corp. Pharmaceuticals: MajorHealth Technology Povides testing and manufacturing services | Health Technology |
BioVeris Corp.
BioVeris Corp. BiotechnologyHealth Technology Develops and manufactures diagnostic products | Health Technology |
